13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based
Key Takeaways
- The landmark PREDIMED trial demonstrated that an energy-unrestricted Mediterranean diet supplemented with extra virgin olive oil or mixed tree nuts reduced major adverse cardiovascular events (MI, stroke, or CV death) by 30% compared to a control low-fat diet in high-risk primary prevention.
- In secondary prevention, the CORDIOPREV randomized controlled trial revealed that a Mediterranean diet achieved a 26% to 28% relative reduction in recurrent major cardiovascular events over 7 years in patients with established coronary artery disease, establishing clear superiority over a low-fat diet.
- The DASH diet, when combined with sodium restriction to 1,500 mg/day, lowers systolic blood pressure by 8 to 14 mmHg in hypertensive individuals, producing hemodynamic benefits equivalent to single-agent antihypertensive pharmacotherapy.
- Plant-based and vegetarian dietary patterns reduce cardiovascular mortality, improve insulin sensitivity, and lower atherogenic lipoproteins, but strict vegan diets require mandatory Vitamin B12 (cobalamin) supplementation to prevent hyperhomocysteinemia and neurologic injury.
- The cardiovascular efficacy of dietary patterns arises from the synergistic interaction of whole foods—unrefined complex carbohydrates, polyphenols, monounsaturated fats, and viscous fibers—rather than isolated micronutrient supplementation.
13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based
[!NOTE] Clinical Competency Core: Nutritional science in cardiovascular disease has transitioned from single-nutrient isolation to holistic dietary patterns. Cardiac rehabilitation professionals must understand the physiological mechanisms, evidentiary foundations, and clinical trial outcomes of the three most extensively validated cardioprotective dietary patterns: the Mediterranean diet, the Dietary Approaches to Stop Hypertension (DASH) diet, and evidence-based plant-based patterns.
Epidemiological and randomized clinical trial evidence underscores that dietary patterns exert profound effects on systemic inflammation, endothelial function, vascular tone, lipid subfractions, and atherothrombosis. Rather than focusing solely on reducing isolated components like total fat or dietary cholesterol, contemporary guideline recommendations from the AACVPR, ACC, and AHA advocate for comprehensive dietary architectures that combine whole, nutrient-dense foods acting synergistically to halt plaque progression.
The Mediterranean Dietary Pattern & Landmark Clinical Trials
The traditional Mediterranean dietary pattern is characterized by high consumption of extra virgin olive oil (EVOO) as the predominant culinary fat; abundant minimally processed plant foods (vegetables, fresh fruits, legumes, whole grains, nuts, and seeds); moderate intake of fish and poultry; low-to-moderate consumption of fermented dairy (yogurt and natural cheese); low intake of red and processed meats, refined grains, and sweets; and optional, moderate consumption of red wine consumed primarily with meals.
Landmark Trial 1: PREDIMED (Primary Prevention)
The PREDIMED (Prevención con Dieta Mediterránea) trial was a multicenter, randomized primary prevention trial conducted in Spain involving 7,447 participants at high cardiovascular risk (type 2 diabetes or ≥3 major cardiovascular risk factors) followed for a median of 4.8 years. Participants were randomized to three groups:
- Mediterranean diet supplemented with extra virgin olive oil (EVOO) (1 liter per week).
- Mediterranean diet supplemented with mixed tree nuts (30 g daily: 15 g walnuts, 7.5 g almonds, 7.5 g hazelnuts).
- Control group advised to follow a low-fat diet.
Key Findings: Both Mediterranean diet groups achieved a statistically significant 30% relative risk reduction in the primary composite endpoint of major adverse cardiovascular events (myocardial infarction, stroke, or cardiovascular death) compared to the low-fat control (Hazard Ratio [HR] 0.69 for EVOO; HR 0.72 for nuts). The benefit was driven primarily by a remarkable reduction in stroke incidence, confirming that an energy-unrestricted Mediterranean diet rich in unsaturated fats provides superior vascular protection compared to traditional fat restriction.
Landmark Trial 2: CORDIOPREV (Secondary Prevention in Established CAD)
While PREDIMED confirmed primary prevention, the CORDIOPREV randomized controlled trial (published in The Lancet in 2022) evaluated 1,002 patients with documented coronary heart disease (aged 20–75 years) followed prospectively over a 7-year follow-up period. Patients were randomized to:
- A Mediterranean diet (at least 35% of total calories from fat, primarily monounsaturated fat from EVOO, 22% protein, and <50% carbohydrates).
- A low-fat, high-complex-carbohydrate diet (<30% total fat, 15% protein, and >55% carbohydrates).
Key Findings: The Mediterranean diet demonstrated clear superiority over the low-fat diet in secondary prevention, achieving a 26% relative risk reduction in recurrent major cardiovascular events (HR 0.741; 95% CI 0.543–0.999). Among male participants (who constituted 82.5% of the study cohort), the relative reduction reached 28% (HR 0.72). CORDIOPREV established the Mediterranean pattern as the definitive standard for secondary prevention dietary management in cardiac rehabilitation.
The DASH Dietary Pattern & Hemodynamic Control
The Dietary Approaches to Stop Hypertension (DASH) eating pattern was designed specifically to test the hypothesis that dietary modifications can lower blood pressure without pharmacotherapy. The DASH architecture is rich in potassium, magnesium, calcium, dietary fiber, and protein, while strictly limiting saturated fat, total fat, and cholesterol.
Core DASH Macronutrient & Food Distribution
- Fruits and Vegetables: 4 to 5 servings/day of each (providing potent natriuretic potassium and magnesium).
- Low-Fat or Fat-Free Dairy Products: 2 to 3 servings/day (supplying bioavailable calcium and bioactive peptides).
- Whole Grains: 6 to 8 servings/day (providing viscous soluble fiber).
- Lean Meats, Poultry, and Fish: ≤6 ounces/day (restricting saturated fat).
- Nuts, Seeds, and Legumes: 4 to 5 servings/week (rich in arginine, a precursor to endothelial nitric oxide).
- Sweets and Added Sugars: ≤5 servings/week.
The Original DASH and DASH-Sodium Trials
In the original DASH feeding trial, the DASH diet reduced systolic blood pressure (SBP) by an average of 5.5 mmHg and diastolic blood pressure (DBP) by 3.0 mmHg in normotensive adults, and by an impressive 11.4 mmHg systolic and 5.5 mmHg diastolic in hypertensive participants compared to a standard American diet.
The subsequent DASH-Sodium trial evaluated three sodium levels (High: 3,300 mg/day; Intermediate: 2,400 mg/day; Low: 1,500 mg/day) crossed with either the control diet or DASH diet. Combining the DASH diet with low sodium (1,500 mg/day) achieved the greatest hemodynamic benefit:
- Normotensive individuals experienced a systolic drop of 7.1 mmHg.
- Hypertensive individuals experienced a dramatic systolic reduction of 11.5 to 14.2 mmHg compared to the high-sodium control diet. This magnitude of blood pressure reduction matches or exceeds that achieved with standard single-agent antihypertensive medication, highlighting the therapeutic potency of combined dietary and electrolyte modification.
Plant-Based and Vegetarian Patterns in Cardiovascular Care
Plant-based diets represent a nutritional continuum ranging from flexitarian/semi-vegetarian (occasional animal products), pesco-vegetarian (plants plus fish), and lacto-ovo vegetarian (plants plus dairy/eggs), to strict vegan and Whole Food Plant-Based (WFPB) diets that exclude all animal-derived foods and heavily processed oils.
Cardiometabolic Mechanisms of Plant-Based Diets
- Endothelial Protection via Dietary Nitrates: Green leafy vegetables and beets are rich in inorganic nitrate ($NO_3^-$), which is reduced by oral commensal bacteria to nitrite ($NO_2^-$) and converted in the gastric and vascular lumens to nitric oxide (NO), stimulating endothelial vasodilation and reducing arterial stiffness independent of endothelial nitric oxide synthase (eNOS).
- Lipid-Lowering Effects: The near-absence of saturated fats combined with high concentrations of phytosterols and viscous fibers upregulates hepatic LDL receptors, routinely lowering LDL-C by 10% to 20%.
- Insulin Sensitivity & Inflammation: High fiber content promotes intestinal production of anti-inflammatory short-chain fatty acids (SCFAs; acetate, propionate, butyrate), suppressing NF-κB signaling and lowering hs-CRP.
Essential Micronutrient Vigilance in Strict Vegans
While plant-based diets confer extensive cardiovascular advantages, strict vegan and WFPB diets mandate careful clinical surveillance for specific micronutrient deficiencies:
- Vitamin B12 (Cobalamin): Found naturally only in animal-derived foods. Strict vegans must consume Vitamin B12-fortified foods or daily supplements (250–1,000 mcg/day or 2,000 mcg/week). Chronic B12 deficiency leads to impaired methionine synthase activity, causing severe hyperhomocysteinemia (an independent endothelial toxin promoting vascular thrombosis) and progressive, irreversible subacute combined degeneration of the spinal cord.
- Iron and Zinc: Plant foods contain non-heme iron and zinc bound to phytates, reducing bioavailability. Clinicians should educate patients to pair iron-rich plant foods (lentils, spinach) with Vitamin C (ascorbic acid) to enhance absorption.
- Long-Chain Omega-3s (EPA/DHA): Vegans rely on plant alpha-linolenic acid (ALA), which exhibits poor conversion to EPA (<5% to 8%) and DHA (<1%). Microalgae-derived EPA/DHA oil supplements should be recommended to ensure optimal anti-inflammatory and membrane-stabilizing benefits.
| Feature / Trial Parameter | Mediterranean Pattern (PREDIMED / CORDIOPREV) | DASH Pattern (DASH-Sodium) | Whole Food Plant-Based (WFPB) |
|---|---|---|---|
| Primary Fat Source | Extra virgin olive oil (≥4 tbsp/day); mixed tree nuts | Low total fat (<27%); vegetable oils in strict moderation | Negligible added oils; whole nuts, seeds, avocados |
| Primary Protein | Fish/seafood (≥2–3x/wk), legumes, poultry; low red meat | Low-fat dairy, lean poultry, fish, beans, seeds | 100% plant: legumes, soy (tofu/tempeh), lentils, nuts |
| Cardiovascular Impact | 30% MACE reduction (primary); 26–28% recurrent MACE reduction (secondary) | 8–14 mmHg systolic BP drop in hypertensives | 10–20% LDL-C reduction; enhanced flow-mediated dilation |
| Key Micronutrient Rule | Maintain moderate sodium; prioritize unrefined foods | Sodium target: 1,500 mg/day for maximal BP benefit | Mandatory Vitamin B12 supplementation (250–1,000 mcg/day) |
Clinical Case Scenario: Dietary Transition in Uncontrolled Hypertension
Clinical Presentation: A 61-year-old male 6 weeks post-coronary artery bypass graft (CABG x3) presents for Phase II cardiac rehab intake. His seated resting blood pressure is 148/92 mmHg despite hydrochlorothiazide 25 mg and lisinopril 20 mg daily. BMI is 29.2 kg/m².
Dietary Assessment:
- The patient follows a standard Western diet high in processed sandwich meats, canned soups, frozen dinners, and commercial chips, with an estimated daily sodium intake exceeding 4,200 mg and minimal fruit/vegetable intake (1 serving/day).
Rehabilitation Intervention:
- Pattern Implementation: Transition the patient to the DASH eating pattern, emphasizing 4 to 5 daily servings each of fresh vegetables and fruits, 3 servings of low-fat dairy, and swapping canned meats for baked salmon and beans.
- Sodium Restriction: Set a sodium target of 1,500 mg/day, utilizing citrus juice, garlic, and fresh herbs instead of table salt.
- Clinical Outcome: After 6 weeks of adherence, the patient's resting blood pressure decreases to 126/78 mmHg (a 22/14 mmHg reduction), allowing his cardiologist to avoid adding a third antihypertensive medication.
In the landmark CORDIOPREV secondary prevention randomized controlled trial published in The Lancet, what was the primary clinical outcome when comparing a Mediterranean diet to a conventional low-fat diet over 7 years in patients with established coronary heart disease?
The original DASH and DASH-Sodium clinical trials evaluated the hemodynamic impact of dietary patterns across varying levels of sodium intake. When hypertensive adults adhered to the combination of the DASH dietary pattern and a low-sodium intake level (1,500 mg daily), what magnitude of systolic blood pressure reduction was observed?
A 52-year-old patient enrolling in cardiac rehabilitation shares that he has adopted a strict vegan (exclusively plant-based) diet following his percutaneous coronary intervention. Which micronutrient deficiency is this patient at highest risk of developing without fortified foods or supplements, and what adverse cardiovascular biomarker elevation is directly caused by this deficiency?
The landmark PREDIMED trial evaluated the efficacy of the Mediterranean diet for primary cardiovascular prevention in 7,447 high-risk participants. Which specific intervention arms were tested, and what was the observed cardiovascular outcome compared to the control low-fat diet?